The BKGD Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-engineered human cell population designed for targeted disruption of the BKGD gene. This product consists of a polyclonal pool of HEK293T cells with heterogeneous editing events, generating a loss-of-function model without clonal isolation. The use of CRISPR/Cas9 technology enables efficient gene disruption, providing researchers with a versatile tool to investigate BKGD function in a physiologically relevant context. These cells are suitable for a broad range of molecular and cellular biology experiments.
The HEK293T host cell line is a widely employed human embryonic kidney epithelial model, known for its adherent growth and high transfectability. Derived from HEK293 cells, HEK293T stably expresses the SV40 large T antigen, which promotes episomal replication of plasmids containing the SV40 origin of replication. This feature enhances protein expression and viral production, making HEK293T a preferred system for gene editing studies, recombinant protein manufacturing, and lentiviral packaging. The robust growth characteristics and well-characterized genetic background contribute to reproducible experimental outcomes.
The BKGD gene encodes a protein whose biological functions remain incompletely characterized. While specific upstream regulators, downstream targets, and signaling pathways are not yet fully defined, the generation of a knockout model in HEK293T cells provides a powerful platform for functional genomics studies. Researchers can employ this system to explore potential roles of BKGD in cellular processes, identify interacting partners through co-immunoprecipitation or proximity labeling, and assess the impact of loss of function on cell proliferation, morphology, or stress responses.
Integrating BKGD knockout into HEK293T cells leverages the host line??s experimental tractability to facilitate detailed mechanistic analyses. The polyclonal nature of the population avoids artifacts associated with single-cell cloning, such as clonal drift, while still enabling robust loss-of-function experiments. The combination of the knockout with HEK293T??s efficient protein expression machinery allows for complementation assays using wild-type or mutant BKGD constructs, thereby supporting structure-function studies. This model is particularly valuable for high-throughput screening applications that require scalable and genetically uniform cell material.
Key research applications include validation of BKGD knockout by Sanger sequencing, quantification of transcript levels via RT-qPCR, and assessment of protein expression through western blotting. Beyond these foundational assays, the cells can be employed in functional screens, drug response studies, and investigation of genetic interactions when combined with additional edits. The polyclonal format is well-suited for pooled library screens and assays that benefit from a diverse allelic series. For further technical information, please contact Ascent Research.
